NEURODEGENRATIVE DISEASES - ANTI-PARKINSON DRUGS, ALZHEIMER DISEASE,MULTIPLE SCLEROSIS, AMYOTROPHIC LATERAL SCLEROSIS
ALSO WATCH PRECISE VIDEOS OF ANTIMICROBIAL
Parkinsonism Neurological disorder of muscle movement, characterized by Tremor, Muscular rigidity, Bradykinesia(slowness ininitiating & carrying voluntary movement) , Postural and gait abnormalities.
Etiology:
imbalance b/w Substantia nigra & Neostriatum...Loss of DOPAMINE results in increased production of Ach in NEOSTRIATUM & decrease Inhibitory effect of DOPAMINE(produce in SUBSTANTIA NIGRA) on Ach...
Levodopa
metabolic precursor of DOPAMINE...only provide Symptomatic relief
MOA
Dopamine does not cross B.B.B..Levodopa actively transported into CNS .converted into Dopamine in Brain...
Carbidopa
DOPA decarboxylase inhibitor...Θ metabolism of Levodopa in GIT & Peripheral tissue...increasing availability of DOPA in brain
T.E
2/3rd of Patient in Parkinson disase reduce severity of disease..
P.K
levodopa 1-2 hr t1/2..ingestion of high protein(Amino ACIDS) may interfere in the transport of Levodopa...should be taken empty stomach
S.E
Dyskinesia(Abnorma involuntary movement), Mydriasis, Blood Dyscrasias, +Ve Coomb‟s test, Hypertension, saliva and urine red color due to melanin pigment produced from catecholamine oxidation
Drug interactions
Pyridoxine (Vit B6) increases breakdown of Levodopa
MOAI & Levodopa coadministration causes Hypertensive crisis
Contraindicated in Glaucoma due to increase intraocular pressure
Antipsychotics contraindicated in Parkinson disease
Selegiline & Rasagiline= Selectively inhibit MOA type B which metabolize
DOPAMINE.. Selegiline also called Deprynyl...
Selegiline metabolized into Methamphetamine & Amphetamine..may produce insomnia
so administered afternoon in Depression Patient
Rasigiline have 5 times more potency of selegiline
COMT INHIBITORS
Entacapone & tolcapone..inhibit the Catechol-O- methylTransferase which convert Levodopa into 3-O-MethylDopa
3-O-MethylDopa compete with Levodopa for active transport into CNS...increased conc. Of levodopa...these drugs help to reduce “wearing off” phenomenon
P.K
plasma binding 98%..Tolcapone enter in CNS & inhibit COMT in CNS, has long t1/2,
S.E
“Fulminating Hepatic Necrosis” caused by Tolcapone
DOPAMINE-RECEPTOR AGONIST
Bromocriptine
Derivative of Vasoconstrictive Ergotamine Alkaoid ,
Coadministration with Levodopa cause mental condition to worse,
S.E
cause vasospasm not used in M.I, pulmonary & retroperitoneal fibrosis, worsen the ulcer
Apomorphine, Pramipexole, Ropinirole, Rotigotine= non-ergot dopamine agonist
Apomorphien & Rotigotine available in injectable and transdermal delievery sys..
Cimetidine inhibit renal tubular secretion of organic base increase t1/2 of Pramipexole
.Flouroquinolone antibiotics inhibit met. Of Ropinirole & increase AUC by 80% ...
Rotigotine treat Early Stage Parkinson‟s disease, O.D patch,
ANTIVIRAL
Amantadine= increase release of DOPAMINE, block cholinergic receptor, inhibit NMDA
DRUG USED IN ALZHEIMER DISEASE
AcetylcholineEsterase Inhibitors=Galantamine, Tacrine, Rivastigmine, Donepzil
NMDA-Receptor anatagonist=Memantine drug.
MOA
Stimulation of Glutamate in CNS essential for making memories.. Binding of Glutamate to NMDA receptor..opening of Na+ & Ca++ channel...activate process damage neuron e.g Apoptosis
Memantine Block NMDA ...prevent neurodegeneration
DRUGS USED IN MULTIPLE SCLEROSIS
Autoimmune inflammatory demyelinating disease of CNS
Mitoxantrone
cytotoxic anthrcycline...kill T-cells...modify the immune sys by destroying anti-inflammatory process that lead to myelin sheath damage & decrease axonal communication b/w cells
Fingolimod
first oral drug ...alters lymphocyte migration, resulting sequestration of lymphocytes in lymph nodes...decrease severity & frequency of M.S
Dalfampridine
K+ channel blocker..improve walking speed...decrease relapse rate
Glatiramer
synthetic polypeptide resemble myelin protein...act as “decoy” to kill T- cells
DRUGS USED IN AMYOTROPHIC LATERAL SCLEROSIS
Riluzole= block glutamate. Sodium channel, calcium channel, improve survival time
Comments
Post a Comment